CordenPharma Lipids & Carbohydrate Platform

CordenPharma Lipids & Carbohydrate Platform
Product Description

Your Expert Partner for Standard & Proprietary Lipids & Carbohydrates

  • >> A specialized Lipids offering including custom and standard lipids (Glycero-Phospholipids, Sphingolipids, Phosphocholine, Pegylated, and Cationic Lipids).
  • >> Lipids for support of mRNA vaccine production including Phosphocholine, Pegylated, Cationic Lipids and highly pure plant-based CP BotaniChol® (cholesterol).
  • >> Fully-integrated service offering > from APIs to finished dosage and pharmaceutical services (clinical trial kits preparation, randomization and logistics).
  • >> Backward integration for key starting materials > securing the supply chain in terms of costs & quality.
  • >> Multiple manufacturing locations across Europe & the USA offering flexibility of supply.

Corden Pharma International GmbH

  • DE
  • 2015
    On CPhI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Manufacturer/Innovator
Specifications
  • Supplied from
    France; Italy; Switzerland; United States

Corden Pharma International GmbH

  • DE
  • 2015
    On CPhI since
  • 1
    Certificates
  • 1000 - 4999
    Employees
Manufacturer/Innovator

More Products from Corden Pharma International GmbH

  • CordenPharma Peptides Platform

    Product CordenPharma Peptides Platform

    Your Expert Partner for Peptide APIs
    • >> Proven track record delivering world class manufacturing services from early stage to commercial supply, including complex products (e.g., Linaclotide, Enfuvirtide, Mifamurtide, Eptifibatide, Glatiramer, GLP analogues).
    • >> Proprietary process technologies for cost-effective manufacturing and a robust CMC dossier by reduced chemical steps, increased purity, decreased raw material costs, and green approaches to reduce our carbon footprint.
    • >> A unique expertise in Peptides offering access to a wide range of products to meet customer needs.
    • >> Fully-integrated supply from peptide APIs to injectable Drug Products, with backward integration for key starting materials to secure supply chain.
    • >> Multiple manufacturing locations across Europe & the USA offering flexibility of supply while supporting our Business Contingency Plan (BCP).
  • CordenPharma Injectables Platform

    Product CordenPharma Injectables Platform

    Your Expert Partner for Clinical & Commercial Injectable Drug Product Supply
    • >> Wide & balanced range of injectable services incl. capability for combining injectable drugs and devices (combination products)
    • >> Aseptic and Terminal Sterilization Fill & Finish Technologies forPre-Filled Syringes (PFS), ampoules, liquid and lyophilized vials, supporting a wide range of filling volumes
    • >> Substantial Drug Product regulatory and filing experience globally (EMEA, FDA, PMDA)
    • >> Full-service CDMO offering, project management & integrated supply from APIs to final Drug Products>> Packaging / labeling
    • >> Clinical trial drug kit management (logistics, track & trace,documentation)

Corden Pharma International GmbH resources

  • News Press Release > Facile & Scalable Synthesis of Plant-Based Cholesterol (BotaniChol®) in GMP Grade

    Luxembourg & Magdeburg, 25 May 2021 -- Chemists at CordenPharma and the Otto-von-Guericke-University of Magdeburg, Germany developed a scalable synthesis of pharma-grade cholesterol based on botanical sources.
  • News Press Release > CordenPharma Colorado to Double its Largest Peptide Purification Suite

    Luxembourg, 13 May 2021 -- In Q4 2020 CordenPharma announced both an expansion of non-GMP capacity at our Centre of Excellence for Peptide Process Development in Frankfurt, Germany, and a major increase in upstream capacity with the introduction of a new 3’000 L Solid Phase Peptide Synthesis (SPPS) vessel in CordenPharma Colorado (US).
  • News Press Release > CordenPharma Colorado Expands Lipid Excipients Purification

    Luxembourg, 19 April 2021 -- In response to the COVID-19 pandemic, mRNA (messenger RNA) vaccines have catapulted to center stage of the pharmaceutical and biotechnology industry. As of early 2021, there are eight ongoing human trials for mRNA vaccines led by Moderna, BioNTech / Pfizer, CureVac, Sanofi / TranslateBio, Arcturus / Duke-NUS Medical School (Singapore), Imperial College London, Chulalongkorn University (Thailand), and Providence Therapeutics.
  • News Top 5 Industry Content Reads on CPhI Online This Month

    If you’re looking for news, product information and market trends from leading pharma companies, the CPhI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partner.

  • News Press Release > CordenPharma Increases US Peptide Manufacturing Capacity to Accommodate Global Market Growth

    Luxembourg, 7 July 2020 - CordenPharma is proud to announce peptide manufacturing capacity expansion in CordenPharma Colorado, their GMP API facility in Boulder, CO (US). Already known for its unique large-scale peptide offering with a 10’000 L SPPS (Solid-Phase Peptide Synthesis) vessel, and a 100 cm high-pressure reverse phase purification column, CordenPharma Colorado is recognized as the largest worldwide peptide API producer leading the global peptide market.
  • News Press Release > CordenPharma & Moderna Extend Lipid Supply Agreement for Moderna’s (mRNA-1273) Vaccine Candidate

    Luxembourg, 28 May 2020 -- CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agreement with Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients.

Recommended products